Cleveland Cavaliers superstar LeBron James is expected to miss the rest of the preseason after getting an anti-inflammatory injection in his back this week. He had received a similar treatment in January that was successful according to Jason Llyod of the Akron Beacon Journal.
James received a similar anti-inflammatory shot in January when he was shut down for two weeks and responded so well that the plan was always for him to have another one at some point, one league source said. By doing it now, James won’t miss any significant time.
James has dealt with back problems the last couple of years, although no one seems to think it’s a significant issue at present.
“We’ll see what happens at the beginning of next week,” Blatt said. “I certainly don’t expect him to play both games and I don’t know if he’ll even play one. We’ll see.”
If James is out for two weeks this time, he will miss the start of the regular season and with so many of the Cavaliers returning from or dealing with injuries, things could be a little rough for a while as discussed earlier this summer in Pro Bball Report.
No less than starting point guard Kyrie Irving, starting power forward Kevin Love, one-time starting center Anderson Varejao and last year’s starting center Timofey Mozgov are all expected to be back (eventually) after serious injuries.
Power forward Tristan Thompson is also unavailable because of a contract dispute.
While no one is anticipating any long term problems with James, back issues are always serious and it should be expected the Cavs will not rush their franchise player back before he’s 100 percent no matter what the early season results are.
This is bad news for the fans in Toronto who were expecting to see James play on Sunday at the Air Canada Centre.